Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells

Kazufumi Wakao(University of Yamanashi), Masahiro Fujimuro(Kyoto Pharmaceutical University), Tadatoshi Takadama(University of Yamanashi), Tadashi Watanabe(Aichi Medical University), Takahiro Taira(Hokkaido University), Chizuka Higashi(University of Yamanashi), Sadaharu Ui(University of Yamanashi), Zenpei Shigemi(Kyoto Pharmaceutical University), Hiroki Kagawa(Kyoto Pharmaceutical University), Rie Ohga(University of Yamanashi)
Biochemical and Biophysical Research Communications
January 13, 2014
10.1016/j.bbrc.2014.01.017
Cited by 34

Related Papers

Best Practice Guidelines for the use of CFD in Nuclear Reactor Safety Applications
|Unknown|2007|197
Preparation of chlorophylls and pheophytins by isocratic liquid chromatography
|Analytical Chemistry|1984|183
Intraoperative Tractography and Motor Evoked Potential (MEP) Monitoring in Surgery for Gliomas Around the Corticospinal Tract
|World Neurosurgery|2010|124
A Novel Glycosylphosphatidyl Inositol-Anchored Protein on Human Leukocytes: A Possible Role for Regulation of Neutrophil Adherence and Migration
|The Journal of Immunology|1999|109
TAG-1–assisted progenitor elongation streamlines nuclear migration to optimize subapical crowding
|Nature Neuroscience|2013|107